NASDAQ:JSPR | Cash Flow Statement | Jasper Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$2.76M
2026-03-31-$1.17M-$14.55M
2025-12-31-$9.1M-$21.87M$0.00-$340,000.00
2025-09-30-$18.74M
2025-06-30-$26.72M
2025-03-31-$21.24M-$22.84M$4,000.00
2024-12-31-$24.32M-$21.13M-$76,000.00$345,000.00
2024-09-30-$18.64M
2024-06-30-$14.58M
2024-03-31-$13.73M-$15.74M-$25,000.00$47.35M
2023-12-31-$16.58M$283,000.00-$16.48M-$230,000.00-$271,000.00
2023-09-30-$17.54M$300,000.00
2023-06-30-$16.08M
2023-03-31-$14.26M-$10.34M-$26,000.00$101.51M
2022-12-31-$13.21M$273,000.00-$12.65M-$82,000.00$28,000.00
2022-09-30-$11.86M$300,000.00
2022-06-30-$10.4M
2022-03-31-$2.21M-$14.21M-$29,000.00$13,000.00
2021-12-31-$9.06M-$14.58M-$711,000.00-$909,000.00
2021-09-30-$3.41M
2021-06-30-$8.41M
2021-03-31-$9.75M-$6.2M-$960,000.00$10.75M
2020-12-31-$53.35M-$5.39M$17,952.00$10.8M
2020-09-30-$201,191.00
2020-06-30-$3.43M
2020-03-31$1.43M-$232,870.00$77,310.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$75.8M-$77.16M$5,000.00$34.21M
2024-12-31-$71.27M-$62.6M-$532,000.00$47.88M
2023-12-31-$64.47M$1.11M-$52.07M-$267,000.00$100.97M
2022-12-31-$37.69M$975,000.00-$45.86M-$576,000.00$55,000.00
2021-12-31-$30.64M-$33.68M-$2.43M$100.97M
2020-12-31-$31.67M-$18.27M$198,343.00$11.29M